We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Erba Mannheim Acquires Maxmat for Diagnostics Analyzers and Advanced Development

By LabMedica International staff writers
Posted on 26 Oct 2015
Through its Czech subsidiary Erba Lachema, Erba Mannheim (Mannheim, Germany) has expanded its portfolio by acquiring Maxmat SA, France, a company emphasizing development and manufacturing of medical laboratory devices based on original patented technologies.

On September 21, 2015, Erba Mannheim successfully completed its acquisition of Maxmat, whose blood analyzers are used in clinical laboratories in Western Europe, the USA, and other countries. Maxmat SA France has been renamed to Erba Diagnostics France SARL (Montpellie, France). Erba Diagnostics France will benefit the entire Erba group with its capabilities and knowhow in the field of design and development of analyzers that perform multiple functions in a laboratory spanning different segments of biochemistry, hemostasis, and immunology. Among its product-line is a revolutionary multi-analyzer that can conduct hundreds of different biochemistry, coagulation, and immunology tests on a sample.

Jaroslav Rehurek, Managing Director of Erba Lachema, said: “For us, Maxmat represents a great potential in the area of development of medical devices, and therefore it is supposed to contribute to additional growth of our company. Moreover, we are sure that its analyzers will soon find customers in our markets. Furthermore, the acquisition offers a highly favorable synergy with the current portfolio of our company.”

The acquisition will help shrink development timelines for new advanced technologies and to fulfill the needs of diagnostic laboratories. Erba Diagnostics France (formerly Maxmat SA) will also improve the group’s presence in France and French-speaking North African countries.

Mr. Suresh Vazirani, Chairman and Managing Director of Erba’s Transasia Bio-Medicals Ltd, stated, “We are excited about the new opportunities that are offered by this strategic acquisition. This acquisition will strengthen the group’s plans to emerge as a global leader in IVD.” Erba Group and Erba Diagnostics France (formerly Maxmat SA) have drawn up growth plans based on achieving economies of scale, widening product offering, creating synergy through intra-group coordination, and strengthening after-sales service support and distribution network.

Related Links:

Erba Mannheim
Erba Diagnostics France




Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
Gold Member
Thyroid-Stimulating Hormone Test
ULTRA-TSH
New
Gold Member
Latex Test
SLE-Latex Test
New
Myocardial Infarction Test
Finecare cTn I/NT-proBNP Rapid Quantitative Test

Latest Industry News

EuroMedLab 2025 Showcases Latest Technologies and Innovations in Laboratory Medicine

Qiagen Acquires NGS Analysis Software Company Genoox

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions